lansoprazole and gastrins

lansoprazole has been researched along with gastrins in 73 studies

Research

Studies (73)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (1.37)	18.7374
1990's	44 (60.27)	18.2507
2000's	19 (26.03)	29.6817
2010's	8 (10.96)	24.3611
2020's	1 (1.37)	2.80

Authors

Authors	Studies
Harada, Y; Ikeda, H; Kawai, T; Saitou, T	1
Håkanson, R; Karlsson, A; Lee, H; Mattsson, H; Sundler, F	1
Berlin, I; Cournot, A; Dellatolas, F; Duchier, A; Duchier, J; Durrel, J; Molinier, P	1
Greski, PA; Hoyos, PA; Jennings, DE; Page, JG; Sanders, SW; Tolman, KG	1
Inada, I; Inatomi, N; Maki, Y; Nagaya, H; Nakamura, N; Nohara, A; Satoh, H	1
Fraker, DL; Jensen, RT	1
Arai, H; Furuta, T; Futami, H; Hanai, H; Kaneko, E	1
Itoh, H; Nakata, H; Nishioka, S	1
Ishii, K; Komuro, Y; Miyake, Y; Oida, M; Saigenji, K; Tanabe, S	1
Hanai, H; Ito, G; Kaneko, E; Nakagawara, M; Nawano, M; Ooi, S; Watanabe, F	1
Brunner, G; Fuchs, W; Hell, M; Hengels, KJ; Hennig, U	1
Cadiot, G; Forestier, S; Joubert-Collin, M; Mignon, M; Paul, G; Ramdani, A; Ruszniewski, P; Vallot, T	1
Bruley des Varannes, S; Dellatolas, F; Galmiche, JP; Lartigue, S; Lemaire, M; Levy, P	1
Sampliner, RE	1
Goff, J; Greski-Rose, P; Jennings, D; Lanza, F; Scowcroft, C	1
Arnold, R	1
Andrieu, J; Coste, T; Dupuis, J; Grimaud, JC; Julien, H; Lemerez, M; Licht, H; Petite, JP; Sallerin, V; Slama, JL	1
Feigenbaum, KM; Jensen, RT; Koviack, PD; Metz, DC	1
Arnold, R; Brunner, G; Fuchs, W; Hennig, U	1
Cadiot, G; Mignon, M; Pospai, D; Potet, F; Ruszniewski, P; Vissuzaine, C	1
Avner, DL; Dorsch, ER; Greski-Rose, PA; Jennings, DE	1
Baniukiewicz, A; Bielański, W; Gabryelewicz, A; Hahn, EG; Jedynak, M; Konturek, PC; Konturek, SJ; Kwiecień, N; Sito, E	1
Castell, DO; Haber, MM; Richter, JE; Robinson, M; Sontag, SJ	1
Campbell, DR; Fleischmann, R; Haber, M; Kogut, DG; Richter, J; Sontag, SJ	1
Isoda, K; Itakura, Y; Itoyama, S; Matsumura, O; Mitarai, T; Murakawa, M; Tamura, H; Tokushima, H	1
Hirschowitz, BI; Mohnen, J; Shaw, S	2
Koike, M; Nio, Y; Sumi, S; Tamura, K; Tanigawa, K; Xu, G	1
Arnold, R; Brunner, G; Eissele, R; Simon, B; Solcia, E	1
Campbell, DR; Castell, D; Fleischmann, R; Kogut, DG; Lehman, GA; McFarland, M; Richter, J; Robinson, M; Sabesin, S; Sontag, SJ	1
Buchi, KN; Jennings, DE; Karol, MD; Ringham, GL; Sanders, SW; Tolman, KG	1
Arroyo Villarino, MT; Esteva Díaz, F; Lanas Arbeloa, A; Ortego Fernández de Retana, J; Sainz Samitier, R	1
Aoki, T; Fukuchi, Y; Kashiwagi, H; Omura, K; Omura, N	1
Goff, J; Greski-Rose, P; Jennings, D; Jhala, N; Lanza, F; Silvers, D; Winters, J	1
Berstad, A; Berstad, AE; Brandtzaeg, P; Hatlebakk, JG; Maartmann-Moe, H	1
Campbell, D; Haber, M; Jennings, DE; Kovacs, TO; Richter, J; Rose, P	2
Arai, H; Baba, S; Furuta, T; Futami, H; Hanai, H; Kajimura, M; Kaneko, E; Takashima, M	1
Aoki, T; Gang, C; Kashiwagi, H; Omura, K; Omura, N	1
Goff, JS	1
Chiba, T; Fukui, H; Hassan, S; Kinoshita, Y; Maekawa, T; Okada, A; Okamoto, H; Waki, S	1
Ariake, K; Fujiki, K; Horiuchi, T; Ishii, K; Kumagai, J; Ohkusa, T; Sakurazawa, T; Shimoi, K; Suzuki, S; Takashimizu, I; Tanizawa, T	1
Fuchs, W; Harder, H; Kiel, G; Pfützer, R; Singer, MV; Stephan, F; Teyssen, S	1
Dobrilla, G; Fiocca, R; Piazzi, L	1
Cryer, B; Feldman, M; Lee, E; Sammer, D; Spechler, SJ	1
Haber, MM; Hirschowitz, BI	1
Bell, N; Greski-Rose, P; Hunt, RH; Jennings, DE; Karol, MD; Sachs, G	1
Chiba, T; Fukuda, R; Ishihara, S; Kawashima, K; Kazumori, H; Kinoshita, Y	1
Her, HH; Jang, JY; Kim, KH; Kim, SW; Park, SJ; Park, YH	1
Fukushima, Y; Hasegawa, J; Ieiri, I; Ishizaki, T; Kishimoto, Y; Kitano, M; Momiyama, K; Morisawa, T; Morita, T; Nakagawa, K; Okochi, H; Otsubo, K	1
Hirschowitz, BI; Mohnen, J; Simmons, J	1
Bell, RH; Longnecker, DS; McDonald, JM	1
Mignon, M; Ramdani, A; Samoyeau, R	1
Fitzgerald, J; Hassall, E; Huang, B; Kane, R; Pilmer, B; Tolia, V	1
Chilton, A; Nwokolo, CU; Pounder, RE; Sercombe, J; Usselmann, B; Williams, MP	1
Anai, M; Asano, T; Fujishiro, M; Fukushima, H; Fukushima, Y; Haraikawa-Onishi, Y; Honda, M; Ichinose, M; Inukai, K; Ishikawa, T; Katagiri, H; Kurihara, H; Kurihara, Y; Nagai, R; Ogihara, T; Ohashi, Y; Omata, M; Ono, H; Saitoh, T; Sakoda, H; Shimizu, Y; Shindo, T; Shojima, N; Wang, Y	1
Fujita, I; Kato, S; Masuda, G; Matsukura, N; Tajiri, T; Togashi, A; Tokunaga, A; Yamada, N	1
Maartmann-Moe, H; Viste, A; Waldum, H; Øvrebø, K	1
Holcberg, G; Mayer, A; Sheiner, E	1
Boyer, K; Tolia, V	1
Haber, M; Hirschowitz, BI; Mohnen, J; Worthington, J	1
El-Zaatari, M; Grabowska, AM; McKenzie, AJ; Powe, DG; Scotting, PJ; Watson, SA	1
Atkinson, SN; Wu, J; Zhang, W	1
Kimakovych, VI; Kovalyshyn, VI; Skliarov, PO	1
Bödvarsdóttir, TB; Gotfredsen, CF; Hove, KD; Karlsen, AE; Petersen, JS; Pridal, L; Vaag, A	1
Arcury, J; Hirschowitz, BI; Seay, T; Wilcox, CM	1
Juul-Hansen, P; Rydning, A	1
Hirata, Y; Joh, T; Kamiya, T; Kataoka, H; Mizoshita, T; Mizushima, T; Nojiri, S; Ozeki, K; Sasaki, M; Shimura, T; Tanida, S; Tatematsu, M; Tsukamoto, H; Tsukamoto, T	1
Han, C; Metz, DC; Perez, MC; Pilmer, BL	1
Fossmark, R; Fougner, R; Hauso, Ø; Jianu, CS; Kleveland, PM; Lange, OJ; Martinsen, TC; Qvigstad, G; Viset, T; Waldum, HL	1
Jovanovic, L; Levetan, C; Pozzilli, P; Schatz, D	1
Ashida, K; Chiba, T; Hiramatsu, N; Iwakiri, K; Kudou, K; Nishimura, A; Sakurai, Y; Umegaki, E	1
Cheon, GJ; Cho, YK; Choi, SC; Hong, SJ; Jung, HK; Jung, HY; Jung, SW; Kim, GH; Kim, HJ; Kim, HS; Kim, JH; Kim, N; Kim, SK; Kim, SS; Kim, TO; Ko, KH; Lee, JY; Lee, KJ; Lee, OY; Lee, SH; Lee, SK; Lee, SP; Lee, ST; Moon, JS; Oh, JH; Park, MI; Rhee, PL; Shin, WG; Sung, IK	1

Reviews

1 review(s) available for lansoprazole and gastrins

Article	Year
Safety of proton pump inhibitors--an overview. Alimentary pharmacology & therapeutics, 1994, Volume: 8 Suppl 1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Benzimidazoles; Cytochrome P-450 Enzyme System; Disease Models, Animal; Drug Interactions; Enterochromaffin Cells; Gastrins; Humans; Lansoprazole; Omeprazole; Pantoprazole; Peptic Ulcer; Proton Pump Inhibitors; Sulfoxides	1994

Trials

41 trial(s) available for lansoprazole and gastrins

Article	Year
Dose ranging study of lansoprazole, a new proton pump inhibitor, in patients with high gastric acid secretion. European journal of clinical pharmacology, 1992, Volume: 43, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphatases; Adult; Double-Blind Method; Drug Administration Schedule; Duodenal Ulcer; Female; Gastric Acid; Gastrins; Humans; Lansoprazole; Male; Omeprazole	1992
The effects of lansoprazole, a new H+,K(+)-ATPase inhibitor, on gastric pH and serum gastrin. Alimentary pharmacology & therapeutics, 1992, Volume: 6, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Circadian Rhythm; Gastric Acidity Determination; Gastrins; Humans; Lansoprazole; Male; Omeprazole	1992
Effects of lansoprazole with or without amoxicillin on ulcer healing: relation to eradication of Helicobacter pylori. Journal of clinical gastroenterology, 1995, Volume: 20 Suppl 2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Ulcer Agents; Duodenal Ulcer; Gastric Juice; Gastric Mucosa; Gastrins; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Penicillins; Pepsinogens; Peptic Ulcer; Proton Pump Inhibitors; Stomach Ulcer	1995
Efficacy of lansoprazole and amoxicillin in eradicating Helicobacter pylori: evaluation using 13C-UBT and Monoclonal H. pylori antibody testing. Journal of clinical gastroenterology, 1995, Volume: 20 Suppl 2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Ulcer Agents; Antibodies, Bacterial; Antibodies, Monoclonal; Breath Tests; Drug Therapy, Combination; Duodenal Ulcer; Gastrins; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Monitoring, Physiologic; Omeprazole; Penicillins; Pepsinogens; Stomach Ulcer; Urea	1995
Effects of lansoprazole on gastric ulcer healing and mucin content. Journal of clinical gastroenterology, 1995, Volume: 20 Suppl 2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Depression, Chemical; Female; Gastric Acid; Gastric Mucosa; Gastrins; Humans; Lansoprazole; Male; Middle Aged; Mucins; Omeprazole; Proton Pump Inhibitors; Stomach Ulcer	1995
Influence of lansoprazole on intragastric 24-hour pH, meal-stimulated gastric acid secretion, and concentrations of gastrointestinal hormones and enzymes in serum and gastric juice in healthy volunteers. Digestion, 1995, Volume: 56, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Eating; Female; Gastric Acid; Gastric Juice; Gastrins; Gastrointestinal Hormones; Humans; Hydrogen-Ion Concentration; Intrinsic Factor; Lansoprazole; Male; Omeprazole; Pepsin A; Pepsinogens	1995
[Comparative efficacy of lansoprazole and omeprazole on the intragastric pH measured over a period of 24 hours and on the basal]. Gastroenterologie clinique et biologique, 1994, Volume: 18, Issue:8-9 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Female; Gastric Acid; Gastric Mucosa; Gastrins; Humans; Hydrogen-Ion Concentration; Lansoprazole; Male; Middle Aged; Omeprazole; Zollinger-Ellison Syndrome	1994
Comparison of lansoprazole with omeprazole on 24-hour intragastric pH, acid secretion and serum gastrin in healthy volunteers. Alimentary pharmacology & therapeutics, 1994, Volume: 8, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Double-Blind Method; Gastric Acid; Gastric Mucosa; Gastrins; Humans; Hydrogen-Ion Concentration; Lansoprazole; Omeprazole; Stomach	1994
Effect of up to 3 years of high-dose lansoprazole on Barrett's esophagus. The American journal of gastroenterology, 1994, Volume: 89, Issue:10 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Barrett Esophagus; Epithelium; Esophagus; Female; Gastrins; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors	1994
Double-blind comparison of lansoprazole, ranitidine, and placebo in the treatment of acute duodenal ulcer. Lansoprazole Study Group. The American journal of gastroenterology, 1994, Volume: 89, Issue:8 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Adult; Anti-Ulcer Agents; Double-Blind Method; Drug Administration Schedule; Duodenal Ulcer; Female; Gastric Mucosa; Gastrins; Helicobacter pylori; Humans; Lansoprazole; Male; Omeprazole; Ranitidine	1994
[Comparison of lansoprazole (30 mg) and omeprazole (20 mg) in the treatment of duodenal ulcer. A multicenter double-blind comparative trial]. Gastroenterologie clinique et biologique, 1993, Volume: 17, Issue:5 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Anti-Ulcer Agents; Double-Blind Method; Duodenal Ulcer; Female; Gastrins; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Pain	1993
Prospective study of the long-term efficacy and safety of lansoprazole in patients with the Zollinger-Ellison syndrome. Alimentary pharmacology & therapeutics, 1993, Volume: 7 Suppl 1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Alanine Transaminase; Anti-Ulcer Agents; Aspartate Aminotransferases; Drug Administration Schedule; Fasting; Female; Follow-Up Studies; Gastrins; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Prospective Studies; Zollinger-Ellison Syndrome	1993
An open trial of long-term therapy with lansoprazole in patients with peptic ulceration resistant to extended high-dose ranitidine treatment. Alimentary pharmacology & therapeutics, 1993, Volume: 7 Suppl 1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance; Duodenal Ulcer; Enterochromaffin Cells; Esophagitis; Female; Follicle Stimulating Hormone; Gastric Mucosa; Gastrins; Humans; Lansoprazole; Luteinizing Hormone; Male; Omeprazole; Peptic Ulcer; Pyloric Antrum; Ranitidine; Stomach Ulcer; Testosterone	1993
A comparison of three doses of lansoprazole (15, 30 and 60 mg) and placebo in the treatment of duodenal ulcer. The Lansoprazole Study Group. Alimentary pharmacology & therapeutics, 1995, Volume: 9, Issue:5 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abdominal Pain; Adult; Aged; Anti-Ulcer Agents; Double-Blind Method; Duodenal Ulcer; Duodenoscopy; Female; Gastrins; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Treatment Outcome; Wound Healing	1995
One week treatment with omeprazole, clarithromycin and tinidazole or lansoprazole, amoxicillin and metronidazole for cure of Helicobacter pylori infection in duodenal ulcer patients. Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 1996, Volume: 47, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastric Acidity Determination; Gastric Mucosa; Gastrins; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Tinidazole	1996
Efficacy and safety of lansoprazole in the treatment of erosive reflux esophagitis. The Lansoprazole Group. The American journal of gastroenterology, 1996, Volume: 91, Issue:9 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Dose-Response Relationship, Drug; Double-Blind Method; Enzyme Inhibitors; Esophagitis, Peptic; Female; Gastric Mucosa; Gastrins; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Time Factors	1996
Lansoprazole prevents recurrence of erosive reflux esophagitis previously resistant to H2-RA therapy. The Lansoprazole Maintenance Study Group. The American journal of gastroenterology, 1996, Volume: 91, Issue:9 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Dose-Response Relationship, Drug; Double-Blind Method; Enzyme Inhibitors; Esophagitis, Peptic; Female; Follow-Up Studies; Gastric Mucosa; Gastrins; Histamine H2 Antagonists; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Recurrence; Time Factors	1996
[Eradication of Helicobacter pylori in patients with end-stage renal disease undergoing dialysis treatment]. Nihon Jinzo Gakkai shi, 1996, Volume: 38, Issue:8 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Ammonia; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Diterpenes; Drug Therapy, Combination; Fatty Alcohols; Female; Gastric Juice; Gastrins; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Peritoneal Dialysis, Continuous Ambulatory; Renal Dialysis	1996
Long-term treatment with lansoprazole of patients with duodenal ulcer and basal acid output of more than 15 mmol/h. Alimentary pharmacology & therapeutics, 1996, Volume: 10, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Duodenal Ulcer; Enzyme Inhibitors; Gastric Acid; Gastric Mucosa; Gastrins; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Patient Dropouts; Prospective Studies; Proton Pump Inhibitors; Zollinger-Ellison Syndrome	1996
Long-term treatment with lansoprazole for patients with Zollinger-Ellison syndrome. Alimentary pharmacology & therapeutics, 1996, Volume: 10, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Enzyme Inhibitors; Female; Gastric Acid; Gastric Mucosa; Gastrins; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Patient Dropouts; Pentagastrin; Proton Pump Inhibitors; Zollinger-Ellison Syndrome	1996
Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy. The American journal of gastroenterology, 1997, Volume: 92, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Antacids; Anti-Ulcer Agents; Double-Blind Method; Drug Resistance; Esophagitis, Peptic; Esophagoscopy; Fasting; Female; Follow-Up Studies; Gastrins; Heartburn; Histamine H2 Antagonists; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Ranitidine; Safety; Sleep; Sleep Stages; Ulcer; Wound Healing	1997
The effects of oral doses of lansoprazole and omeprazole on gastric pH. Journal of clinical gastroenterology, 1997, Volume: 24, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Anti-Ulcer Agents; Area Under Curve; Cross-Over Studies; Double-Blind Method; Gastrins; Humans; Hydrogen-Ion Concentration; Lansoprazole; Male; Omeprazole; Stomach	1997
Effects of long-term treatment with lansoprazole and omeprazole on serum gastrin and the fundic mucosa. Revista espanola de enfermedades digestivas, 1997, Volume: 89, Issue:5 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Double-Blind Method; Female; Gastric Mucosa; Gastrins; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Stomach Ulcer	1997
Prevention of duodenal ulcer recurrence with 15 mg lansoprazole: a double-blind placebo-controlled study. The Lansoprazole Study Group. Digestive diseases and sciences, 1997, Volume: 42, Issue:12 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Biopsy; Double-Blind Method; Duodenal Ulcer; Female; Gastrins; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Recurrence	1997
Double-blind comparison of lansoprazole 15 mg, lansoprazole 30 mg, and placebo in the maintenance of healed gastric ulcer. Digestive diseases and sciences, 1998, Volume: 43, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Biopsy; Cell Count; Double-Blind Method; Enterochromaffin-like Cells; Female; Follow-Up Studies; Gastric Mucosa; Gastrins; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Recurrence; Stomach Ulcer; Time Factors	1998
Disappearance of hyperplastic polyps in the stomach after eradication of Helicobacter pylori. A randomized, clinical trial. Annals of internal medicine, 1998, Nov-01, Volume: 129, Issue:9 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abietanes; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Diterpenes; Drug Therapy, Combination; Female; Gastrins; Helicobacter Infections; Helicobacter pylori; Humans; Hyperplasia; Immunoglobulin G; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Polyps; Proton Pump Inhibitors; Single-Blind Method; Statistics, Nonparametric; Stomach Neoplasms	1998
Double-blind comparison of lansoprazole 15 mg, lansoprazole 30 mg and placebo as maintenance therapy in patients with healed duodenal ulcers resistant to H2-receptor antagonists. Alimentary pharmacology & therapeutics, 1999, Volume: 13, Issue:7 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Double-Blind Method; Drug Resistance; Duodenal Ulcer; Female; Gastric Mucosa; Gastrins; Histamine H2 Antagonists; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Recurrence; Treatment Outcome; United States	1999
Effect of 7-day therapy with different doses of the proton pump inhibitor lansoprazole on the intragastric pH in healthy human subjects. Scandinavian journal of gastroenterology, 1999, Volume: 34, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Evaluation; Enzyme Inhibitors; Gastric Acidity Determination; Gastrins; Humans; Hydrogen-Ion Concentration; Lansoprazole; Male; Omeprazole; Postprandial Period; Proton Pump Inhibitors; Time Factors	1999
Lansoprazole versus omeprazole for duodenal ulcer healing and prevention of relapse: a randomized, multicenter, double-masked trial. Clinical therapeutics, 1999, Volume: 21, Issue:8 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Anti-Ulcer Agents; Double-Blind Method; Duodenal Ulcer; Endoscopy; Female; Gastrins; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Secondary Prevention; Time Factors	1999
Influence of H. pylori infection on meal-stimulated gastric acid secretion and gastroesophageal acid reflux. The American journal of physiology, 1999, Volume: 277, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Esophagitis; Female; Food; Gastric Acid; Gastric Emptying; Gastric Mucosa; Gastrins; Gastritis; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Lansoprazole; Male; Middle Aged; Monitoring, Physiologic; Omeprazole; Penicillins; Polyethylene Glycols; Postprandial Period; Solvents	1999
Duration of effect of lansoprazole on gastric pH and acid secretion in normal male volunteers. Alimentary pharmacology & therapeutics, 2001, Volume: 15, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Double-Blind Method; Enzyme Inhibitors; Gastric Acid; Gastric Acidity Determination; Gastric Mucosa; Gastrins; Humans; Lansoprazole; Male; Omeprazole; Pentagastrin; Time Factors	2001
Comparison of the kinetic disposition of and serum gastrin change by lansoprazole versus rabeprazole during an 8-day dosing scheme in relation to CYP2C19 polymorphism. European journal of clinical pharmacology, 2001, Volume: 57, Issue:6-7 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphatases; Adult; Anti-Ulcer Agents; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Benzimidazoles; Cross-Over Studies; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme System; Female; Gastrins; Genotype; Humans; Lansoprazole; Male; Mixed Function Oxygenases; Omeprazole; Polymorphism, Genetic; Proton Pump Inhibitors; Proton-Translocating ATPases; Rabeprazole	2001
Effect of pantoprazole versus other proton pump inhibitors on 24-hour intragastric pH and basal acid output in Zollinger-Ellison syndrome. Gastroenterologie clinique et biologique, 2002, Volume: 26, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Female; Gastric Acid; Gastric Acidity Determination; Gastrins; Humans; Lansoprazole; Male; Omeprazole; Pantoprazole; Prospective Studies; Proton Pump Inhibitors; Sulfoxides; Time Factors; Zollinger-Ellison Syndrome	2002
Safety of lansoprazole in the treatment of gastroesophageal reflux disease in children. Journal of pediatric gastroenterology and nutrition, 2002, Volume: 35 Suppl 4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Child; Child, Preschool; Dose-Response Relationship, Drug; Esophagitis; Female; Gastrins; Gastroesophageal Reflux; Humans; Infant; Lansoprazole; Male; Omeprazole; Proton Pump Inhibitors; Safety	2002
Eradication of Helicobacter pylori increases nocturnal intragastric acidity during dosing with rabeprazole, omeprazole, lansoprazole and placebo. Alimentary pharmacology & therapeutics, 2003, Mar-15, Volume: 17, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Benzimidazoles; Breath Tests; Cross-Over Studies; Female; Gastric Acid; Gastrins; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Lansoprazole; Male; Omeprazole; Rabeprazole; Urea	2003
Helicobacter pylori eradication therapy for the remnant stomach after gastrectomy. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2003, Volume: 6, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abietanes; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Biomarkers; Biopsy; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Follow-Up Studies; Gastrectomy; Gastric Stump; Gastrins; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Lansoprazole; Male; Middle Aged; Omeprazole; Pepsinogen A; Pepsinogen C; Proton Pump Inhibitors; Proton Pumps; Randomized Controlled Trials as Topic; Severity of Illness Index; Time Factors; Treatment Outcome	2003
Effects of dexlansoprazole MR, a novel dual delayed release formulation of a proton pump inhibitor, on plasma gastrin levels in healthy subjects. Journal of clinical pharmacology, 2009, Volume: 49, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Chemistry, Pharmaceutical; Cross-Over Studies; Delayed-Action Preparations; Dexlansoprazole; Dose-Response Relationship, Drug; Female; Gastrins; Humans; Lansoprazole; Male; Middle Aged; Proton Pump Inhibitors	2009
Presentation, response to lansoprazole therapy, and outcome of Zollinger-Ellison syndrome-like gastric acid hypersecretors. Scandinavian journal of gastroenterology, 2011, Volume: 46, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Biopsy; Drug Administration Schedule; Female; Follow-Up Studies; Gastric Acid; Gastric Acidity Determination; Gastric Mucosa; Gastrins; Gastroscopy; Humans; Lansoprazole; Male; Middle Aged; Prospective Studies; Stomach; Stomach Ulcer; Treatment Outcome; Zollinger-Ellison Syndrome	2011
Clinical and pathophysiological consequences of on-demand treatment with PPI in endoscopy-negative reflux disease. Is rebound hypersecretion of acid a problem? Scandinavian journal of gastroenterology, 2011, Volume: 46, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Chromogranins; Esophagitis; Female; Gastric Acid; Gastrins; Heartburn; Humans; Lansoprazole; Laryngopharyngeal Reflux; Male; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Secretory Rate	2011
Randomised clinical trial: a dose-ranging study of vonoprazan, a novel potassium-competitive acid blocker, vs. lansoprazole for the treatment of erosive oesophagitis. Alimentary pharmacology & therapeutics, 2015, Volume: 42, Issue:6 Topics: Adult; Aged; Dose-Response Relationship, Drug; Double-Blind Method; Esophagitis; Female; Gastrins; Humans; Lansoprazole; Los Angeles; Male; Middle Aged; Proton Pump Inhibitors; Pyrroles; Sulfonamides	2015
Randomised clinical trial: comparison of tegoprazan and lansoprazole as maintenance therapy for healed mild erosive oesophagitis. Alimentary pharmacology & therapeutics, 2023, Volume: 57, Issue:1 Topics: Gastrins; Humans; Lansoprazole	2023

Other Studies

31 other study(ies) available for lansoprazole and gastrins

Article	Year
[Changes in the rat stomach after long-term administration of proton pump inhibitors (AG-1749 and E-3810)]. Nihon rinsho. Japanese journal of clinical medicine, 1992, Volume: 50, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphatases; Animals; Benzimidazoles; Gastric Acid; Gastrins; H(+)-K(+)-Exchanging ATPase; Lansoprazole; Male; Omeprazole; Parietal Cells, Gastric; Rabeprazole; Rats; Rats, Inbred Strains; Stomach; Vacuoles	1992
Lansoprazole and omeprazole have similar effects on plasma gastrin levels, enterochromaffin-like cells, gastrin cells and somatostatin cells in the rat stomach. Digestion, 1992, Volume: 51, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphatases; Animals; Enterochromaffin Cells; Female; Gastric Acid; Gastrins; Histamine; Histidine Decarboxylase; Lansoprazole; Omeprazole; Parietal Cells, Gastric; Rats; Rats, Inbred Strains; Somatostatin; Stomach	1992
Antisecretory and antiulcer activities of a novel proton pump inhibitor AG-1749 in dogs and rats. The Journal of pharmacology and experimental therapeutics, 1989, Volume: 248, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphatases; Animals; Anti-Ulcer Agents; Dogs; Gastric Acid; Gastric Mucosa; Gastrins; H(+)-K(+)-Exchanging ATPase; In Vitro Techniques; Lansoprazole; Male; Omeprazole; Pepsin A; Peptic Ulcer; Protons; Rats; Rats, Inbred Strains	1989
Zollinger-Ellison syndrome. Advances in treatment of gastric hypersecretion and the gastrinoma. JAMA, 1994, May-11, Volume: 271, Issue:18 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Blood Chemical Analysis; Combined Modality Therapy; Duodenal Neoplasms; Female; Gastric Acid; Gastric Mucosa; Gastrinoma; Gastrins; Hepatic Artery; Humans; Interferons; Lansoprazole; Male; Middle Aged; Multiple Endocrine Neoplasia; Omeprazole; Pancreatic Neoplasms; Peptic Ulcer; Splenic Artery; Zollinger-Ellison Syndrome	1994
Factors affecting quality of ulcer healing after lansoprazole treatment. Journal of clinical gastroenterology, 1995, Volume: 20 Suppl 2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Age Factors; Alcohol Drinking; Anti-Ulcer Agents; Duodenal Ulcer; Female; Gastric Acid; Gastrins; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Pepsinogens; Peptic Ulcer; Proton Pump Inhibitors; Sex Factors; Smoking; Stomach Ulcer	1995
[Effect of prolonged treatment with proton pump inhibitors on serum gastrin levels and the fundus mucosa. Preliminary results]. Gastroenterologie clinique et biologique, 1995, Volume: 19, Issue:10 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Duodenal Ulcer; Enzyme Inhibitors; Female; Gastric Fundus; Gastrins; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Prospective Studies; Proton Pump Inhibitors; Time Factors	1995
Role of endogenous hypergastrinemia in regenerating endocrine pancreas after partial pancreatectomy. Digestive diseases and sciences, 1996, Volume: 41, Issue:12 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Blood Glucose; Gastrins; Insulin; Lansoprazole; Male; Omeprazole; Organ Size; Pancreas; Pancreatectomy; Proteins; Proton Pump Inhibitors; Rats; Rats, Wistar; Regeneration	1996
Gastric mucosa during treatment with lansoprazole: Helicobacter pylori is a risk factor for argyrophil cell hyperplasia. Gastroenterology, 1997, Volume: 112, Issue:3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Female; Gastric Mucosa; Gastrins; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Hyperplasia; Lansoprazole; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Pyloric Antrum; Risk Factors	1997
Effects of enprostil on gastric endocrine secretion during chronic administration of lansoprazole. Journal of gastroenterology, 1997, Volume: 32, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Drug Interactions; Enprostil; Enterochromaffin Cells; Gastric Mucosa; Gastrin-Secreting Cells; Gastrins; Immunohistochemistry; Lansoprazole; Male; Omeprazole; Rats; Rats, Wistar; Somatostatin; Somatostatin-Secreting Cells; Stomach	1997
Helicobacter pylori gastritis and epithelial cell proliferation in patients with reflux oesophagitis after treatment with lansoprazole. Gut, 1997, Volume: 41, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Cell Division; Epithelial Cells; Esophagitis, Peptic; Gastric Mucosa; Gastrins; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Immunohistochemistry; Lansoprazole; Middle Aged; Omeprazole; Proton Pump Inhibitors; Statistics, Nonparametric; Time Factors	1997
Effect of Helicobacter pylori infection on gastric juice pH. Scandinavian journal of gastroenterology, 1998, Volume: 33, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Ammonia; Amoxicillin; Anti-Ulcer Agents; Case-Control Studies; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastric Acid; Gastric Juice; Gastric Mucosa; Gastrins; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Proton Pump Inhibitors; Stomach Ulcer	1998
Effect of pirenzepine on gastric endocrine cell kinetics during lansoprazole administration. Journal of gastroenterology, 1998, Volume: 33, Issue:5 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Enterochromaffin Cells; Gastric Mucosa; Gastrin-Secreting Cells; Gastrins; Kinetics; Lansoprazole; Male; Muscarinic Antagonists; Omeprazole; Pirenzepine; Proton Pump Inhibitors; Rats; Rats, Wistar; Somatostatin; Somatostatin-Secreting Cells	1998
Lansoprazole: a cause of secretory diarrhea. The American journal of gastroenterology, 1998, Volume: 93, Issue:11 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Aged, 80 and over; Anti-Ulcer Agents; Diarrhea; Female; Gastrins; Humans; Lansoprazole; Omeprazole; Proton Pump Inhibitors	1998
Regenerating gene protein may mediate gastric mucosal proliferation induced by hypergastrinemia in rats. Gastroenterology, 1998, Volume: 115, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Cell Division; Cells, Cultured; Enterochromaffin-like Cells; Gastric Mucosa; Gastrins; Gene Expression Regulation; Indoles; Lansoprazole; Male; Omeprazole; Rats; Rats, Sprague-Dawley; Regeneration	1998
Helicobacter pylori effects on gastritis, gastrin and enterochromaffin-like cells in Zollinger-Ellison syndrome and non-Zollinger-Ellison syndrome acid hypersecretors treated long-term with lansoprazole. Alimentary pharmacology & therapeutics, 2001, Volume: 15, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Enterochromaffin-like Cells; Enzyme Inhibitors; Female; Gastric Acid; Gastrins; Gastritis; Helicobacter pylori; Humans; Hyperplasia; Intestinal Mucosa; Lansoprazole; Male; Metaplasia; Middle Aged; Omeprazole; Zollinger-Ellison Syndrome	2001
Analysis of gastrin receptor gene expression in proliferating cells in the neck zone of gastric fundic glands using laser capture microdissection. FEBS letters, 2001, Feb-02, Volume: 489, Issue:2-3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Cell Division; Dissection; Gastric Fundus; Gastric Mucosa; Gastrins; Gene Expression Regulation; Immunohistochemistry; Lansoprazole; Lasers; Male; Omeprazole; Proliferating Cell Nuclear Antigen; Rats; Rats, Wistar; Receptors, Cholecystokinin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stomach	2001
Endogenous gastrin stimulates regeneration of remnant pancreas after partial pancreatectomy. Digestive diseases and sciences, 2001, Volume: 46, Issue:10 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Enzyme Inhibitors; Gastrins; Lansoprazole; Male; Omeprazole; Pancreatectomy; Rats; Rats, Sprague-Dawley; Receptors, Cholecystokinin; Regeneration	2001
Minor effects of Helicobacter pylori on gastric secretion and dose of lansoprazole during long-term treatment in ZE and non-ZE acid hypersecretors. Alimentary pharmacology & therapeutics, 2002, Volume: 16, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Gastric Acid; Gastrins; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Pepsin A; Prospective Studies; Zollinger-Ellison Syndrome	2002
Effect of hypergastrinemia on pancreatic carcinogenesis. American journal of surgery, 2002, Volume: 183, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenoma; Animals; Anti-Ulcer Agents; Azaserine; Carcinoma in Situ; Carcinoma, Acinar Cell; Disease Models, Animal; Gastrins; Lansoprazole; Male; Omeprazole; Organ Size; Pancreas; Pancreatic Neoplasms; Precancerous Conditions; Rats; Rats, Inbred Lew	2002
Structural and functional characterization of gastric mucosa and central nervous system in histamine H2 receptor-null mice. European journal of pharmacology, 2003, May-02, Volume: 468, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Blotting, Northern; Electroshock; Gastric Acid; Gastric Mucosa; Gastrins; Gene Targeting; Hydrogen-Ion Concentration; Hyperplasia; Immunohistochemistry; Lansoprazole; Mice; Omeprazole; Pain Threshold; Proton Pump Inhibitors; Receptors, Histamine H2; Seizures	2003
Lanzoprazole promotes gastric carcinogenesis in rats with duodenogastric reflux. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2004, Volume: 7, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenocarcinoma; Administration, Oral; Animals; Duodenogastric Reflux; Enzyme Inhibitors; Gastrins; Lansoprazole; Male; Omeprazole; Rats; Rats, Wistar; Stomach Neoplasms	2004
Zollinger Ellison syndrome, treated with lansoprazole, during pregnancy. Archives of gynecology and obstetrics, 2007, Volume: 276, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Female; Gastrinoma; Gastrins; Humans; Infant, Newborn; Lansoprazole; Male; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Zollinger-Ellison Syndrome	2007
Long-term proton pump inhibitor use in children: a retrospective review of safety. Digestive diseases and sciences, 2008, Volume: 53, Issue:2 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Child; Child, Preschool; Esophagitis; Female; Gastrins; Humans; Lansoprazole; Liver Function Tests; Male; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Retrospective Studies; Vitamin B 12	2008
Chromogranin A in patients with acid hypersecretion and/or hypergastrinaemia. Alimentary pharmacology & therapeutics, 2007, Sep-15, Volume: 26, Issue:6 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Chromogranin A; Confounding Factors, Epidemiologic; Enterochromaffin Cells; Enterochromaffin-like Cells; Female; Gastrins; Humans; Lansoprazole; Male; Middle Aged; Time Factors; Treatment Outcome; Zollinger-Ellison Syndrome	2007
Cyclopamine inhibition of the sonic hedgehog pathway in the stomach requires concomitant acid inhibition. Regulatory peptides, 2008, Feb-07, Volume: 146, Issue:1-3 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Gastric Acid; Gastric Mucosa; Gastrins; Hedgehog Proteins; Lansoprazole; Mice; Mice, Transgenic; Signal Transduction; Stomach; Veratrum Alkaloids	2008
[Morphological changes in the intestinal mucosa of the large intestine under the blockage of H+,K+ -ATPase and CCK-2 gastrin receptors]. Fiziolohichnyi zhurnal (Kiev, Ukraine : 1994), 2009, Volume: 55, Issue:5 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Cell Proliferation; Enzyme Inhibitors; Gastrins; Intestinal Mucosa; Intestine, Large; Lansoprazole; Proglumide; Proton Pump Inhibitors; Rats; Receptor, Cholecystokinin B	2009
Treatment with a proton pump inhibitor improves glycaemic control in Psammomys obesus, a model of type 2 diabetes. Diabetologia, 2010, Volume: 53, Issue:10 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Analysis of Variance; Animals; Blood Glucose; Diabetes Mellitus, Type 2; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Gastrins; Gerbillinae; Hyperglycemia; Immunohistochemistry; Insulin; Insulin-Secreting Cells; Lansoprazole; Male; Proton Pump Inhibitors	2010
Long-term high-dose proton pump inhibitor administration to Helicobacter pylori-infected Mongolian gerbils enhances neuroendocrine tumor development in the glandular stomach. Asian Pacific journal of cancer prevention : APJCP, 2011, Volume: 12, Issue:4 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Carcinoma; Cell Transformation, Neoplastic; Chromogranin A; Gastric Inhibitory Polypeptide; Gastrins; Gerbillinae; Helicobacter Infections; Helicobacter pylori; Lansoprazole; Male; Neoplasms, Glandular and Epithelial; Neuroendocrine Tumors; Proton Pump Inhibitors; Stomach Neoplasms	2011
Withdrawing PPI therapy after healing esophagitis does not worsen symptoms or cause persistent hypergastrinemia: analysis of dexlansoprazole MR clinical trial data. The American journal of gastroenterology, 2011, Volume: 106, Issue:11 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Dexlansoprazole; Esophagitis; Female; Gastric Acid; Gastrins; Heartburn; Humans; Lansoprazole; Male; Middle Aged; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Retrospective Studies; Severity of Illness Index; Withholding Treatment	2011
Gastric neuroendocrine carcinoma after long-term use of proton pump inhibitor. Scandinavian journal of gastroenterology, 2012, Volume: 47, Issue:1 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Carcinoma, Neuroendocrine; Chromogranin A; Gastrins; Gastroesophageal Reflux; Humans; Lansoprazole; Male; Middle Aged; Proton Pump Inhibitors; Stomach Neoplasms; Time Factors	2012
Proposal for generating new beta cells in a muted immune environment for type 1 diabetes. Diabetes/metabolism research and reviews, 2013, Volume: 29, Issue:8 Topics: Animals; Cyclosporine; Diabetes Mellitus, Type 1; Double-Blind Method; Drug Therapy, Combination; Gastrins; Humans; Immune Tolerance; Insulin-Secreting Cells; Lansoprazole; Mice; Pancreatic Ducts; Prospective Studies; Proton Pump Inhibitors; Regeneration; Species Specificity	2013